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Abstract 
Background: With the dramatic increase in international travel among Chinese people, the risk of malaria importa‑
tion from malaria‑endemic regions threatens the achievement of the malaria elimination goal of China.
Methods: Epidemiological investigations of all imported malaria cases were conducted in nine provinces of China 
from 1 Nov, 2013 to 30 Oct, 2014. Plasmodium species, spatiotemporal distribution, clinical severity, preventive meas‑
ures and infection history of the imported malaria cases were analysed using descriptive statistics.
Results: A total of 1420 imported malaria cases were recorded during the study period, with P. falciparum (723 cases, 
50.9 %) and P. vivax (629 cases, 44.3 %) being the two predominant species. Among them, 81.8 % of cases were in 
Chinese overseas labourers. The imported cases returned from 41 countries, mainly located in Africa (58.9 %) and 
Southeast Asia (39.4 %). About a quarter (25.5 %, 279/1094) of counties in the nine study provinces were affected by 
imported malaria cases. There were 112 cases (7.9 %) developing complicated malaria, including 12 deaths (case fatal‑
ity rate: 0.8 %). Only 27.8 % of the imported cases had taken prophylactic anti‑malarial drugs. While staying abroad, 
27.7 % of the cases had experienced two or more episodes of malaria infection. The awareness of clinical manifesta‑
tions and the capacity for malaria diagnosis were weak in private clinics and primary healthcare facilities.
Conclusions: Imported malaria infections among Chinese labourers, returned from various countries, poses an 
increasing challenge to the malaria elimination programme in China. The risk of potential re‑introduction of malaria 
into inland malaria‑free areas of China should be urgently addressed.
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Background
Malaria, transmitted via the bite of infected Anopheles 
mosquitoes, is one of the most important parasitic dis-
eases to affect mankind with a heavy burden of disease 
[1]. Globally an estimated 3.3 billion people are at risk 
of being infected with malaria and developing disease. 
In 2013, 198 million cases of malaria occurred, leading 
to 584,000 deaths [2]. Due to joint efforts made by the 
international community, the global burden of malaria 
has decreased substantially during recent decades [3], 
with a 47 % decline in malaria mortality rates globally, 
averting an estimated 4.3 million deaths between 2001 
and 2013 [4]. In 2015, the World Health Organization 
(WHO) set an ambitious new target of reducing the 
global malaria burden by 90  % by 2030, and encour-
aged nation members to fulfill the goal of malaria 
elimination [4].
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Malaria is a mandatory notifiable infectious disease in the 
People’s Republic of China, with each case required to be 
reported through the National Infectious Disease Reporting 
Information System [5]. Historically, malaria has been the 
most prevalent infectious disease in P.R.China, accounting 
for more than 24 million cases during the early 1970s [6]. 
Long-term implementation of anti-malaria campaigns in 
areas with high transmission of malaria in P.R.China, includ-
ing strengthening surveillance systems, improving access to 
treatment, preventive anti-malarial administration for high-
risk groups, environmental improvement, vector control, 
and social mobilization, has resulted in an unprecedented 
decrease in number of malaria-endemic areas in mainland 
China [7, 8]. Autochthonous malaria cases have numbered 
in only the hundreds annually during the past several years 
[7–10]. The call for global malaria elimination advocated by 
WHO was responded actively in P.R.China, with a national 
malaria elimination action plan being launched by the Chi-
nese central government in 2010, which intends to reach the 
goal of malaria elimination nationwide by 2020 [11–13]. A 
challenge is the globalization strategy for economic devel-
opment in P.R.China, which is resulting in more cases of 
imported malaria in recent years [14–16]. Of particular 
concern is the threat to individual health of Chinese citizens 
travelling abroad, and the potential re-introduction of local 
transmission in malaria-free areas when travellers return. To 
facilitate better response strategies for this new challenge, 
the epidemiological features of imported malaria need to be 
further explored. In this study, a case-based epidemiologi-
cal survey on each imported malaria case was conducted in 
nine provinces of China. The characteristics of importation 
origin, Plasmodium species, prevention, infection, and clini-
cal outcome of imported malaria are described.
Methods
In P.R.China, malaria cases are diagnosed by clinicians in 
accordance with the unified national diagnostic criteria. 
Laboratory-confirmed malaria cases refer to patients with 
any positive result in the following diagnostic tests relat-
ing to malaria: malaria parasites confirmed by micros-
copy, rapid diagnostic tests (RDT), or polymerase chain 
reaction (PCR) tests. Since the initiation of the National 
Malaria Elimination Action Plan in 2010, each case should 
be investigated by local staff at county level of the Centre 
of Disease Control and Prevention, and each case should 
be classified as local or imported malaria [11]. A malaria 
patient is classified as an imported case if the individual 
travelled to a malaria-endemic country within the previ-
ous month [17]. In this study, the last country destination 
of travel was taken as the origin of malaria infection; a 
person who went abroad as a member of a group organ-
ized by an agency was identified as a group traveller; oth-
erwise a person was identified as an individual traveller.
All imported malaria cases reported in the National 
Infectious Disease Reporting Information System in nine 
selected provinces of China were further investigated on 
their detailed travel history, preventive measure, clini-
cal presentation and outcome. Among all 31 provinces 
in mainland China, nine provinces were selected as the 
study setting, based on a willingness to participant in the 
survey, geographic location, levels of incidence of malaria 
in the past 3 years (2010–2012), population, and num-
bers of overseas travellers in 2012 (Table 1) [18, 19]. The 
overall population in the nine selected provinces was 0.58 
billion, which accounted for 43.3 % of the population in 
the whole country. During the period of 1 November, 
2013 to 30 October, 2014, each imported laboratory-
confirmed malaria case in these nine provinces was inter-
viewed face-to-face, using a standard questionnaire, by 
the epidemiological staff at the county level of the Cen-
tre for Disease Control and Prevention. Individual-level 
information on age, gender, residence address, medical 
care-seeking process, symptoms, laboratory test results, 
travel history, clinical presentation, and outcome were 
collected. As one part of national malaria elimination 
plan, this study was approved by the Chinese Centre for 
Disease Control and Prevention, and all individual identi-
fication information was concealed in the database when 
performing data analysis.
Demographic data, Plasmodium species profiles, spa-
tiotemporal distribution of cases, case detection and 
clinical features, as well as preventive measures and 
exposure histories during travel abroad were analysed. 
A seasonal index was used to understand the seasonal 
patterns of imported malaria occurrence. An index for a 
given month (i.e., May) was calculated by case numbers 
for that month (i.e., May) divided by the monthly mean 
of cases during the whole 12 months of the survey [20]. 
No obvious seasonal pattern was expected if the sea-
sonal index of each month was close to 1.0. Medical ser-
vice providers for malaria diagnosis were categorized by 
private clinic, primary hospital, hospital at county level, 
and hospital at city level, according to their popula-
tion coverage and the techniques, equipment, and staff 
available.
Results
Demographic profile
From 1 Nov, 2013 to 30 Oct, 2014, a total of 1420 
imported malaria cases were reported in the study prov-
inces. The mean age of the imported malaria cases was 
36.8  years old (range 1–69, IQR 28–45), and 87.4  % 
(1241 cases) were aged between 21 and 50 years. Males 
accounted for 95 % of all cases. Overseas labourers were 
the most frequent occupational group with malaria infec-
tion, accounting for 81.8 % of all imported cases.
Page 3 of 9Li et al. Malar J  (2016) 15:141 
Plasmodium species by origin and location
P. falciparum (723 cases, 50.9 %) and P. vivax (629 cases, 
44.3  %) were the two predominant species. Only 26 
P. malariae cases and 31 P. ovale cases were detected. 
Nine mixed infections were recorded, which included 
seven cases of P. falciparum mixed with P. vivax, one case 
of P. falciparum and P. malariae, and one case of P. vivax 
and P. malariae. The remaining two malaria cases were 
not sub-typed by species.
Imported cases came from 41 countries located in 
Africa, Asia, Oceania, and Europe, with Africa (841 cases, 
59.2 %) and Southeast Asia (561 cases, 39.5 %) being the 
most common regions of origin. Myanmar was by far the 
leading country with 452 imported cases (Fig. 1a).
The major species of imported malaria varied by sub-
region. P. vivax predominated in imported cases return-
ing from Southeast Asia (80.4  %) and eastern Africa 
(67.5 %), while P. falciparum predominated in cases from 
western Africa (81.3  %), central Africa (83.1  %), and 
southern Africa (86.2 %). P. malariae and P. ovale mainly 
came from central and West Africa (Fig. 1b).
Among the 1094 counties of the nine study provinces, 
25.5 % (279 counties) were affected by imported malaria 
cases. The three leading provinces in terms of numbers of 
cases were Yunnan (477 cases), Sichuan (249 cases) and 
Henan provinces (201 cases). In Yunnan Province, three 
counties that shared land borders with Myanmar were 
the most severely affected with more than 50 imported 
cases each. The majority of imported cases (933 cases, 
65.7 %) came from non-adjacent countries to China, and 
the remaining 487 cases (34.3 %) had returned from adja-
cent countries (Myanmar, Laos, India, and Pakistan).
The main species of Plasmodium varied among the 
study provinces. In Yunnan and Gansu provinces, most 
of the cases (89.7 %, 444/495) came from Southeast Asia, 
with P. vivax being the most predominant species. Most 
of the imported cases (85.5  %, 791/925) in the other 
seven provinces, including Liaoning, Shandong, Sichuan, 
Henan, Shanghai, Hunan, and Guangdong, had returned 
from Africa, with the predominant species being P. falci-
parum (Fig. 2).
Temporal features
There were on average 118 imported malaria cases per 
month (range: 61–191), with May (198 cases) and June 
(179 cases) having the highest numbers according to 
arrival date, with a seasonal index of 1.7 and 1.5 in May 
and June, respectively (Fig.  3). Similarly, May, June and 
July had the highest numbers of cases by disease onset 
date. The median interval between arrival date in China 
and onset of illness was 8 days (IQR 2.8–21  days), with 
84  % of the cases developing the illness within 30  days 
after arrival, and 91.8 % within 60 days.
Case detection and clinical outcome
More than 22  % of imported cases sought medical 
assistance through private clinics and primary hos-
pitals after having developed the illness. Imported 
malaria cases were laboratory diagnosed after having 
experienced an average of 1.1 medical visits, with 107 
cases being confirmed by laboratory testing after two 
or more visits. In total, 78.8 % of all cases were labora-
tory confirmed by hospitals at county level and above. 
During the initial medical care visit, the overall propor-
tion of malaria testing performed was 73.4  % among 
all levels of medical institution, with only 7.9 % of the 
total in private clinics and 30.2 % in primary hospitals 
(Table 2).
Table 1 Background information on the nine study provinces for imported malaria surveys, in China
a Refers to person-times of overseas visitors who enter mainland China
Areas Geographic  
location
Population in  
2012 (000s)
International travellers  
in 2012a (000s)
Total malaria cases 
2010–2012
Entire country – 1,347,890 116,265.7 13,928
Overall of nine study  
provinces (% of entire country)
– 584,060 (43.3 %) 61,944.0 (53.3 %) 7296 (52.4 %)
   Liaoning Northeast 43,890 4731.3 38
   Gansu Northwest 25,780 102.0 278
 Henan Central 94,060 1907.7 1358
 Shandong Central 96,850 4699.1 479
 Shanghai East 23,800 6512.3 117
 Hunan South 66,390 2245.5 323
 Guangdong South 105,940 34,894.3 91
 Sichuan Southwest 80,760 2273.4 667
 Yunnan Southwest 46,590 4578.4 3945
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Proportion of cases for whom a travel history to 
malaria-endemic countries was recorded during the ini-
tial visit was found to be as high as 95.6  % in patients 
attending hospitals at city level, but was much lower in 
private clinic (37.7 %). The median intervals were 2 days 
(IQR 0–4 days) from symptom onset to first medical visit 
and 2 days (IQR 0–5 days) from the first medical visit to 
malaria diagnosis.
Among the 1420 imported cases, 945 were treated in an 
outpatient department, and 475 cases were hospitalized 
for treatment (with a hospitalized proportion of 33.4 %), of 
whom 12 died (giving a case fatality rate of 0.8 %). The four 
leading symptoms were fever (97.9 %), chills (81.6 %), sweat-
ing (71.0 %), and headache (64.9 %) (Table 3). A total of 112 
cases (7.9  %) developed complicated symptoms, the most 
frequent among in-patients being liver function impairment 
Fig. 1 The geographic location of importation origin by country and the Plasmodium species of imported malaria by region. (a the importation 
origin by country, b percentages of infections by region caused by each species of Plasmodium, P. f Plasmodium falciparum, P. v Plasmodium vivax, 
others including Plasmodium malariae and Plasmodium ovale)
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Fig. 2 The spatial distribution of imported malaria by county, the species of Plasmodium and travel destination of the imported malaria by province 
in the nine study provinces of China. a Gansu province, b Liaoning province, c Shandong province, d Sichuan province, e Henan province, f Shang‑
hai city, g Yunnan province, h Hunan province, i Guangdong province, j Location of the study nine provinces
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(8.0  %), gastrointestinal damage (6.7  %), acute renal dys-
function (5.3 %), and coma (5.3 %). The proportion of hos-
pitalization for P. falciparum cases was 46.2  % (334/723), 
which was much higher than that for P. vivax cases (18.1 %, 
114/629). Among the 12 deaths, the median age was 
46 years (range 31–55), which was significantly higher than 
that of the survivors (37 years, range 1–69) (two independ-
ent samples Wilcoxon test, Z = −2.36, p = 0.018).
Preventive measures and infection history
Among the 1261 cases (88.8 % of total) who travelled indi-
vidually or as a part of a group was determined, 738 cases 
(58.5  %) went abroad as a group, and 523 cases (41.5  %) 
travelled individually. Of the group travellers, 52.4  % 
had been trained on malaria prevention measures by the 
organizing agency. Anti-malarial medication was obtained 
by 27.8  % of the cases prior to their overseas travel; the 
figure was 11.3  % among individual travellers. Mosquito 
repellents were obtained by 40.5 % of patients before travel; 
the figure was 21.4 % for individual travellers. The overall 
proportion of bed net usage during the period abroad was 
73.4 %. The median period abroad was 157 days; for group 
travellers, the period was longer (221 days) than for indi-
vidual travellers (72 days). Nearly half of the cases (50.4 %) 
had been diagnosed with malaria infection during the 
period abroad and 27.7 % of the cases had experienced two 
or more episodes of malaria infection.
Discussion
This study found that a large number of imported malaria 
cases were detected in P.R.China, and that overseas 
labourers were the most frequently affected group. The 
countries of origin of the infections were widely distrib-
uted in Africa and Southeast Asia. Many imported cases 
presented with complicated symptoms, leading to 12 
deaths. The awareness of clinical manifestations and the 
capacity for malaria diagnosis were weak in private clin-
ics and primary healthcare facilities.
Due to global economic integration and the rapid eco-
nomic development of China, large numbers of Chinese 
Fig. 3 The monthly distribution of imported malaria cases by arrival date and illness onset date in the study provinces of China, 2013–2014
Table 2 The detection of imported malaria cases by different health providers in nine provinces of China
Item Overall Private clinics Primary  
hospitals
Hospitals at county 
level
Hospitals 
at city level
Number (%) of initial medical visit 1420 215 (15.1) 106 (7.5) 443 (31.2) 656 (46.2)
Proportion of cases for whom laboratory  
testing was done during the initial medical 
visit  % (no. tested/all)
73.4 (1042/1420) 7.9 (17/215) 30.2 (32/106) 87.1 (386/443) 87.7 (575/656)
Number (%) of laboratory‑confirmed cases 1420 153 (10.8) 148 (10.4) 406 (28.6) 713 (50.2)
Proportion of cases for whom a travel  
history was recorded during the initial  
visit  % (no. recorded/all)
82.7 (1175/1420) 37.7 (81/215) 80.2 (85/106) 78.1 (346/443) 95.6 (627/656)
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people travel to malaria-endemic countries for financial 
investment, commercial trade, labour, and tourism. Accord-
ing to the report from the Chinese Bureau of Exit and Entry 
Administration, more than 83 million people went abroad 
to seek job opportunities, travel or study overseas in 2012 
[21]. The relationship between the increased economic 
investment and numbers of exported labourers to Africa 
from China and the increased number of cases imported 
has been well established [15]. Overseas labourers engaged 
in road or bridge building, mining and other outdoor activi-
ties are the highest risk group for malaria infection [14–16]. 
Overseas labourers usually work on construction sites and 
experience poor living conditions with a lack of access to 
mosquito control measures. Additionally, Chinese labourers 
generally lack immunity to local Plasmodium species, espe-
cially to P. falciparum in Africa, and exported labourers are 
generally poorly educated and lack awareness of the risk of 
malaria and personal protection against mosquito bites [22]. 
Guidelines on malaria chemoprophylaxis for international 
travellers should be developed in China, so as to reduce the 
risk of malaria infection among high-risk groups.
With the widespread occurrence of imported malaria, 
several threats are now facing China. Firstly, a large num-
ber of imported cases were due to P. falciparum, the spe-
cies most commonly associated with severe disease and 
death, meaning that prompt diagnosis and appropriate 
treatment are critical [3]. However, this Plasmodium spe-
cies was relatively rare in most settings in China, and most 
healthcare workers at primary level lack awareness and 
skills to diagnose and manage cases infected with falcipa-
rum malaria [23]. Furthermore, a report on one large-scale 
cluster of imported malaria cases returning from Ghana 
showed that about 34.4 % of Plasmodium-positive persons 
had asymptomatic infections [14], which further compli-
cates timely detection by routine malaria surveillance sys-
tem. Therefore, it is estimated in this study that nearly 30 % 
of imported cases were likely under-reported. In addition, 
whilst most local transmission of malaria in China has 
been successfully interrupted [24], wide distribution of 
A. sinensis throughout the country may make many areas 
receptive to transmission [25]. As a result, imported vivax 
malaria may lead to re-introduction in areas that have 
been free of malaria for many years [26, 27], presenting a 
threat to nationwide malaria elimination by 2020.
Along with the rapid development of international trade 
and overseas travel in China, it is expected that the situa-
tion of disease importation will become more problematic 
if effective preventive measures are not undertaken [9, 
28]. Malaria infection prevention measures, intensive sur-
veillance and medical service delivery to exported labour-
ers should be prioritized by the Chinese public health 
authorities [13, 29]. Intersectorial cooperation between 
Table 3 Clinical manifestation of imported malaria cases by outpatient and inpatient in nine provinces of China
P.f. Plasmodium falciparum, P.v. Plasmodium vivax
Clinical features Overall  
(n = 1420)
Outpatients
n = 945
Inpatients
n = 475
P.f.
(n = 389)
P.v.
(n = 515)
All
(n = 945)
P.f.
(n = 334)
P.v.
(n = 114)
All
(n = 475)
Common signs/symptoms 1412 (99) 383 (98.5 %) 514 (99.8 %) 938 (99.3 %) 333 (99.7 %) 113 (99.1 %) 474 (99.8 %)
 Fever 1390 (97.9 %) 372 (95.6 %) 509 (98.8 %) 920 (97.4 %) 331 (99.1 %) 113 (99.1 %) 470 (98.9 %)
 Chills 1159 (81.6 %) 282 (72.5 %) 474 (92.0 %) 785 (83.1 %) 248 (74.3 %) 104 (91.2 %) 374 (78.7 %)
 Sweating 1008 (71.0 %) 249 (64.0 %) 423 (82.1 %) 697 (73.8 %) 203 (60.8 %) 90 (78.9 %) 311 (65.5 %)
 Headache 921 (64.9 %) 234 (60.2 %) 383 (74.4 %) 640 (67.7 %) 188 (56.3 %) 79 (69.3 %) 281 (59.2 %)
 Malaise 414 (29.2 %) 122 (31.4 %) 147 (28.5 %) 281 (29.7 %) 92 (27.5 %) 35 (30.7 %) 133 (28.0 %)
 Dizziness 272 (19.2 %) 89 (22.9 %) 85 (16.5 %) 181 (19.2 %) 66 (19.8 %) 22 (19.3 %) 91 (19.2 %)
 Diarrhoea 168 (11.8 %) 42 (10.8 %) 41 (8.0 %) 87 (9.2 %) 44 (13.2 %) 5 (4.4 %) 81 (17.1 %)
Complicated signs/symptoms 112 (7.9 %) 0 0 0 95 (28.4 %) 17 (14.9 %) 112 (23.6 %)
 Coma 38 (2.7 %) 0 0 0 25 (7.5 %) 0 25 (5.3 %)
 Cerebral lesion 32 (2.3 %) 0 0 0 22 (6.6 %) 1 (0.9 %) 23 (4.8 %)
 Gastro‑intestinal damage 25 (1.8 %) 0 0 0 23 (6.9 %) 9 (7.9 %) 32 (6.7 %)
 Liver function impairment 25 (1.8 %) 0 0 0 38 (11.4 %) 0 38 (8.0 %)
 Acute renal dysfunction 23 (1.6 %) 0 0 0 23 (6.9 %) 0 23 (4.8 %)
 Severe anaemia 23 (1.6 %) 0 0 0 21 (6.3 %) 4 (3.5 %) 25 (5.3 %)
 Haemolysis 19 (1.3 %) 0 0 0 17 (5.1 %) 2 (1.8 %) 19 (4.0 %)
 Shock 7 (0.5 %) 0 0 0 7 (2.1 %) 0 7 (1.5 %)
 Acidosis 5 (0.4 %) 0 0 0 4 (1.2 %) 1 (0.9 %) 5 (1.1 %)
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public health, medical, commercial, and travel sectors 
could play a critical role in the prevention, detection and 
management of imported malaria. Training of local epide-
miologists and physicians on malaria case diagnosis and 
investigation needs to be enhanced. The epidemiologi-
cal features of imported malaria cases and the impact of 
imported cases on malaria elimination in China should be 
further explored with long-term data.
One of the limitations on this study was that, as the 
survey was retrospectively performed, the information 
on imported case exposure, infection and treatment 
history when staying abroad may have some recall bias, 
given that the travellers had lived and worked overseas 
for a long time at the time of survey. In addition, as only 
imported cases diagnosed as malaria were enrolled in 
this study, the population of travellers returned to China 
from various countries during the survey period was 
unavailable, and thereby the incidence of malaria among 
overseas travellers could not be estimated.
Conclusions
This study shows that overseas infections of malaria have 
become a major threat to Chinese labourers travelling 
to countries in West Africa, East Africa, and Southeast 
Asia. In order to reduce the infection risk of malaria dur-
ing periods abroad, awareness and effective protective 
measures against exposure to mosquitoes and malaria 
parasites among high-risk groups should be enhanced. 
The need to improve capacity for imported case detec-
tion and the timeliness of anti-malarial treatments should 
be highlighted, so as to reduce burden of severe malaria 
disease and deaths, as well as prevent secondary malaria 
transmission within China.
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